Mark Kent Buys 14,848 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Mark Kent bought 14,848 shares of the company’s stock in a transaction on Tuesday, June 2nd. The stock was bought at an average cost of $13.31 per share, for a total transaction of $197,626.88. Following the completion of the acquisition, the insider directly owned 14,848 shares of the company’s stock, valued at approximately $197,626.88. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Alignment Healthcare Trading Up 4.5%

Alignment Healthcare stock opened at $14.25 on Thursday. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The business’s fifty day simple moving average is $18.43 and its two-hundred day simple moving average is $19.34. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $23.87. The company has a market capitalization of $2.95 billion, a price-to-earnings ratio of 158.33, a price-to-earnings-growth ratio of 1.91 and a beta of 1.14.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, April 30th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. During the same period in the previous year, the company posted ($0.05) earnings per share. The company’s revenue for the quarter was up 33.3% compared to the same quarter last year. As a group, equities analysts predict that Alignment Healthcare, Inc. will post 0.19 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on ALHC. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a report on Thursday, May 7th. Barclays lowered their price target on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. JPMorgan Chase & Co. upped their price target on Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Wolfe Research began coverage on Alignment Healthcare in a report on Friday, April 17th. They set an “outperform” rating and a $24.00 price target on the stock. Finally, Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.30.

More Alignment Healthcare News

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Alignment Healthcare was named to Fortune’s 2026 Fortune 1000 list for the second year in a row, rising more than 196 spots to No. 791. The recognition highlights strong operating momentum, with fiscal 2025 revenue up 46.1% to $3.95 billion and membership growth driving results. Article: Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year
• Positive Sentiment: Recent commentary says the stock may be oversold after its steep multi-week decline, with analysts still revising earnings estimates higher. That has fueled expectations for a possible near-term turnaround. Article: Down 25.5% in 4 Weeks, Here’s Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaround
• Positive Sentiment: Insider buying also provided a confidence signal, with insider Mark Kent purchasing 14,848 shares at $13.31 each. Article: Insider Buying: Alignment Healthcare (NASDAQ:ALHC) Insider Buys 14,848 Shares of Stock
• Neutral Sentiment: The company also announced executive leadership updates, including John Kao assuming the role of chairman. This is more of a governance update than a direct operating catalyst. Article: Alignment Healthcare (ALHC) Announces Executive Leadership Updates as John Kao Assumes Role of Chairman
• Neutral Sentiment: Another note on valuation and prior analyst downgrades may be keeping investors focused on the stock’s sharp pullback, even as longer-term fundamentals remain tied to revenue growth and Medicare Advantage expansion. Article: A Look At Alignment Healthcare (ALHC) Valuation After Analyst Downgrades And A Sharp 30-Day Share Price Slide
• Negative Sentiment: Some recent coverage emphasized that the stock had fallen sharply over the prior month and was hit by analyst downgrades, which helps explain why sentiment remains mixed despite the positive company news. Article: Alignment Healthcare (ALHC) Slashes 13% on Analyst Downgrade

Institutional Trading of Alignment Healthcare

A number of hedge funds have recently bought and sold shares of ALHC. Wellington Management Group LLP increased its position in Alignment Healthcare by 167.3% during the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after acquiring an additional 6,940,277 shares during the last quarter. Bank of New York Mellon Corp increased its position in Alignment Healthcare by 232.5% during the first quarter. Bank of New York Mellon Corp now owns 3,313,110 shares of the company’s stock valued at $58,377,000 after acquiring an additional 2,316,777 shares during the last quarter. Invesco Ltd. increased its position in Alignment Healthcare by 122.3% during the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after acquiring an additional 2,294,739 shares during the last quarter. Capital World Investors purchased a new stake in Alignment Healthcare during the fourth quarter valued at $44,203,000. Finally, Loomis Sayles & Co. L P purchased a new stake in Alignment Healthcare during the fourth quarter valued at $44,162,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.